Article Information
History
- March 7, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hanna Jensen, PharmD1,
- Zaid Yousif, PharmD, MAS2,
- Trina Huynh, PharmD1,
- Megan Kraushaar, RCS3,
- Marcy Reed, RDCS3,
- Trista Boarman, RN3,
- Jorge Silva Enciso, MD3 and
- Andrew Willeford, PharmD, PhD2,*
- 1UC San Diego Health, Department of Pharmacy, San Diego, California, USA
- 2UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California, USA
- 3UC San Diego Health, Department of Medicine, Division of Cardiovascular Medicine, San Diego, California, USA
- ↵*Corresponding author: Andrew Willeford, University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, 9255 Pharmacy Lane, MC 0657, La Jolla, Ca 92093-0657, t: 858-249-4030, f: 858-657-8239, awilleford{at}health.ucsd.edu
Posted March 07, 2024.
Outcomes of a Multidisciplinary Approach to Management of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
